CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new cobalt-based catalytic systems for cancer treatment. By utilizing organometallic complexes, it aims to create safer and more effective therapies through in-cell redox catalysis, exploring their mechanisms of action in cancer cells.
The search of new therapies for cancer is a primary EU mission.
In-cell redox catalysis promoted by organometallic complexes of precious metals as Ru(II), Os(II), Rh(III) and Ir(III) is a novel promising concept to access more efficient, safer, and less invasive medicines.
Co-CaReD aims to design new in-cell catalytic systems based on half-sandwich Co(III) complexes.
Cobalt combines effective catalytic performances for biomedical applications and high catalytic versatility.
Moreover, it is a che…
FUNDACION IMDEA NANOCIENCIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
